Cardizem Cd Patent Expiration

Cardizem Cd is a drug owned by Bausch Health Us Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 08, 2012. Details of Cardizem Cd's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5439689 Diltiazem formulation
Aug, 2012

(12 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Cardizem Cd is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Cardizem Cd's family patents as well as insights into ongoing legal events on those patents.

Cardizem Cd's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Cardizem Cd's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 08, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Cardizem Cd Generics:

Diltiazem Hydrochloride is the generic name for the brand Cardizem Cd. 35 different companies have already filed for the generic of Cardizem Cd, with Actavis Labs Fl Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Cardizem Cd's generic

How can I launch a generic of Cardizem Cd before its drug patent expiration? :

You can seek FDA approval to launch a generic drug before the expiration of Cardizem Cd's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Cardizem Cd's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Given below are the details of the already filed Para IV certificates on Cardizem Cd -

Strength Submission Date ANDA(s) Filed First applicant approval Last patent expiry 180 day status
120 mg, 180 mg, 240 mg, 300 mg and 360 mg

Alternative Brands for Cardizem Cd

Cardizem Cd which is used for treating hypertension and angina pectoris., has several other brand drugs in the same treatment category and using the same active ingredient (Diltiazem Hydrochloride). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
Bausch
Cardizem La

(uses Diltiazem Hydrochloride)

Used for managing high blood pressure and chest pain.

Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Diltiazem Hydrochloride. Given below is the list of those drugs and companies owning them.

Drug Owner Drug Name
Bausch
Tiazac
Biovail
Diltiazem Hydrochloride


Apart from brand drugs containing the same ingredient, some generics have also been filed for Diltiazem Hydrochloride, Cardizem Cd's active ingredient. Check the complete list of approved generic manufacturers for Cardizem Cd





About Cardizem Cd

Cardizem Cd is a drug owned by Bausch Health Us Llc. It is used for treating hypertension and angina pectoris. Cardizem Cd uses Diltiazem Hydrochloride as an active ingredient. Cardizem Cd was launched by Bausch in 1992.

Approval Date:

Cardizem Cd was approved by FDA for market use on 10 August, 1992.

Active Ingredient:

Cardizem Cd uses Diltiazem Hydrochloride as the active ingredient. Check out other Drugs and Companies using Diltiazem Hydrochloride ingredient

Treatment:

Cardizem Cd is used for treating hypertension and angina pectoris.

Dosage:

Cardizem Cd is available in capsule, extended release form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
120MG CAPSULE, EXTENDED RELEASE Prescription ORAL
180MG CAPSULE, EXTENDED RELEASE Prescription ORAL
240MG CAPSULE, EXTENDED RELEASE Prescription ORAL
300MG CAPSULE, EXTENDED RELEASE Prescription ORAL
360MG CAPSULE, EXTENDED RELEASE Prescription ORAL